Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

321
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Albumin as a dynamic extracellular redox regulator: from Cys34 oxidation biomarkers to polysulfide-mediated homeostatic mechanisms and clinical applications.

Redox report : communications in free radical research·2026
Same author

Organ Crosstalk in CKD-Associated Frailty: Mechanistic Insights, Translational Opportunities, and Clinical Implications.

Biological & pharmaceutical bulletin·2026
Same author

Rat DCST1 and DCST2 are essential for sperm-egg fusion†.

Biology of reproduction·2026
Same author

Inhibition of TRPC3-Nox2 Complex Formation Ameliorates Skeletal Muscle Atrophy.

Antioxidants (Basel, Switzerland)·2026
Same author

TRPC3 and TRPC6: Multimodal Cation-Conducting Channels Regulating Cardiovascular Contractility and Remodeling.

Cells·2026
Same author

Secreted protein acidic and rich in cysteine-guided biomimetic delivery of nano-antioxidants reverses muscle atrophy in a mouse model of sarcopenia.

Journal of controlled release : official journal of the Controlled Release Society·2025

相关实验视频

Updated: Jan 17, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

706

α1-酸糖蛋白通过调节肝脏和脂肪组织功能来缓解MASLD的进展.

Ayano Nishinoiri1, Kai Tokumaru1, Gai Kanazawa2

  • 1Department of Clinical Pharmacy and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.

Endocrinology
|January 15, 2026
PubMed
概括

降低α-1-酸性糖蛋白 (AGP) 水平会恶化与代谢功能障碍相关的脂肪性肝病 (MASLD). 补充AGP通过保护肝脏和脂肪组织显示治疗潜力,这表明AGP具有治疗潜力.

关键词:
AGP AGP 公司 公司脂肪组织炎症 脂肪组织炎症脂肪酸β-氧化 脂肪酸β-氧化肝激素 (hepatokine) 是一种肝激素.马斯尔德 马斯尔德是什么意思线粒体中的线粒体.

更多相关视频

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.6K

相关实验视频

Last Updated: Jan 17, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

706
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.6K

科学领域:

  • 肝病学 肝病学是一种肝病学.
  • 代谢疾病 代谢疾病
  • 生物化学 生物化学

背景情况:

  • 肝激素失调与代谢功能障碍相关的脂肪性肝病 (MASLD) 有关.
  • 一种肝素的α-1-酸糖蛋白 (AGP) 正在研究其在MASLD进展中的作用.

研究的目的:

  • 调查AGP在MASLD进展中的作用.
  • 评估AGP对MASLD的治疗潜力.

主要方法:

  • 来自MASLD患者的肝脏RNA-seq数据集的分析.
  • 使用高脂肪饮食 (HFD) 诱导的MASLD.小鼠模型.
  • 雇佣的AGP-Knockout (AGP-KO) 小鼠和外源的人类AGP (hAGP) 的管理.

主要成果:

  • 肝脏AGP基因表达随着MASLD进展而降低.
  • 在HFD的AGP-KO小鼠中,表现出肥胖症,肥胖症,炎症和葡萄糖耐受性受损的恶化.
  • hAGP通过减少线粒体功能障碍和脂肪组织炎症,保护了小鼠的脂毒性,并减轻了小鼠的MASLD进展.

结论:

  • 降低内源性AGP水平可能会推动MASLD的进展.
  • AGP显示出作为MASLD新型治疗剂的潜力,其向肝脏和脂肪组织.